Ning Liu

机构：Nanjing Drum Tower Hospital · ORCID：0000-0001-5499-5849

发表论文 53 篇 · 总被引 1537 次 · h-index 21

代表论文

• Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside (2024 · Cell Death and Disease · 被引 67)
• Up-regulation of NMRK2 mediated by TFE3 fusions is the key for energy metabolism adaption of Xp11.2 translocation renal cell carcinoma (2022 · Cancer Letters · 被引 44)
• MiR-101: An Important Regulator of Gene Expression and Tumor Ecosystem (2022 · Cancers · 被引 33)
• 5mC and H3K9me3 of TRAF3IP2 promoter region accelerates the progression of translocation renal cell carcinoma (2022 · Biomarker Research · 被引 32)
• Recent Advances on the Role of ATGL in Cancer (2022 · Frontiers in Oncology · 被引 27)
• Landscape of young breast cancer under 35 years in China over the past decades: a multicentre retrospective cohort study (YBCC-Catts study) (2023 · EClinicalMedicine · 被引 26)